Free CME from PeerView


Urology CME

Credits: 0.5 CME
Penn State College of Medicine
Controlling the Urgency Emergency, Restoring QOL: Safe and Effective Management of Overactive Bladder
David Staskin, MD
September 09, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 1.0 CME
Penn State College of Medicine
Transforming Bladder Cancer Treatment: Essential Guidance for Urologists on Therapeutic Selection, Safety, and Sequencing Along the Disease Continuum
Ashish M. Kamat, MD, MBBS
July 08, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Blazing the Trail Forward in the Therapeutic Management of Bladder Cancer: Expert Insights on Incorporating the Latest Evidence and Treatment Advancements Into Practice Across the Disease Continuum
Petros Grivas, MD, PhD
June 07, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic Castration-Sensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Refining RCC Management Across the Disease Continuum: An Expert Clinical Consult on Leveraging New Evidence and Novel Therapeutic Strategies to Personalize Patient Care
Toni K. Choueiri, MD
June 04, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Multidisciplinary Guidance on Translating the Latest Therapeutic Advances Into Patient Care for Early to Advanced Bladder Cancer: Clinical Consults and Cases From the Community
Ashish M. Kamat, MD, MBBS
May 15, 2022
Credits: 1.5 CME / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interprofessional Insights on Optimizing Outcomes With Novel Targeted and Immune-Based Therapies
Nancy P. Moldawer, RN, MSN
May 01, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Robert Dreicer, MD, MS, MACP, FASCO
February 19, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions
Petros Grivas, MD, PhD
February 18, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Carrying Through in Advanced/Metastatic Urothelial Carcinoma: Expert Perspectives on Recent Practice‐Changing Data and the Practicalities of Individualizing and Continuing Care With Novel Immunotherapy Maintenance Strategies
Petros Grivas, MD, PhD
December 29, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
Robert Dreicer, MD, MS, MACP, FASCO / Pedro C. Barata, MD, MSc
December 01, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
Petros Grivas, MD, PhD
December 01, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing Tides in Advanced Endometrial Cancer: A Visual Exploration of Current and Emerging Strategies to Maximize the Potential of Cancer Immunotherapies
Jubilee Brown, MD
November 30, 2021
Credits: 0.5 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
PrEP for All Ages: A Comprehensive Look at Employing HIV Prevention Strategies Across All Age Groups
Richard Elion, MD / Rupa R. Patel, MD, MPH, DTM&H
November 18, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The HIV Prevention–Certified Provider Program: A Training and Certificate Program Designed to Improve Competencies and Expand the HIV Prevention Workforce
Donna E. Sweet, MD, AAHIVS, MACP
November 12, 2021
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD
September 29, 2021
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
Deborah K. Armstrong, MD
July 06, 2021
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
Toni K. Choueiri, MD
July 05, 2021
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
Matthew D. Galsky, MD
June 23, 2021
PVI, PeerView Institute for Medical Education
New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease
Sumanta Kumar Pal, MD
June 21, 2021
Medical Learning Institute, Inc.
The New Therapeutic Era in Renal Cell Carcinoma: Essentials for Team-Based Patient Care
May 17, 2021
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
Evan J. Lipson, MD
May 11, 2021
Medical Learning Institute, Inc.
Enhancing Personalized Medicine in Advanced Ovarian Cancer: Expert Guidance on Integrating the Latest Updates on PARP Inhibitors and Novel Therapeutic Innovations Into Your Clinical Practice
May 11, 2021
Medical Learning Institute, Inc.
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
Suresh S. Ramalingam, MD, FACP, FASCO
May 11, 2021
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
May 07, 2021
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Matthew D. Galsky, MD
April 20, 2021
Medical Learning Institute, Inc.
Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Robert Dreicer, MD, MS, MACP, FASCO
March 03, 2021
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Professor Thomas Powles, MBBS, MRCP, MD
March 03, 2021
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView